Recursion · 1 day ago
Associate Director, Drug Discovery Toxicology
New York, NY
Full-time
Hybrid
Senior Level, Lead/Staff, Director/Executive
$183K/yr - $230K/yr
7+ years expRecursion is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. They are seeking an experienced Drug Discovery Toxicologist to provide scientific expertise and leadership for safety assessments of drug discovery programs, contributing to the selection and optimization of novel drug candidates.
Artificial Intelligence (AI)BiotechnologyMachine LearningPharmaceuticalSoftwareTherapeutics
Responsibilities
Represent Toxicology as the Subject Matter Expert on cross-functional project teams within Discovery
Provide expert input, guidance and strategy on project safety assessments, with a specific focus on discovery projects
Act as a key resource for early safety assessment during the drug discovery phase, providing scientific knowledge and expertise to cross-functional project teams
Use established toxicology screening strategies to predict, assess and mitigate target- and drug-related safety risks in support of the drug discovery portfolio
Refine and implement innovative experimental strategies and use the data to assess and/or provide mechanistic understanding of safety issues
Collaborate with CROs to ensure best practice for in vitro and/or in vivo safety assessment
Prepare verbal and written summaries for internal discussions. Work with the Discovery teams to develop optimal strategies to address specific safety issues within the project teams
Present summary data to project teams, Recursion senior leadership and external partners as needed
Qualification
Required
DVM, PharmD, PhD in toxicology, Pathology, Physiology, Biochemistry or expertise in related biological scientific disciplines with an emphasis on Oncology/Immunology is preferred
Board Certification in Toxicology (DABT/ERT) is a plus
7+ years experience in safety sciences in the Biotech/Pharma industry
Experience in project team membership as a toxicology representative in a matrix environment
Experience with in silico and in vitro safety assessment is a must
Experience with in vivo safety assessment would be an advantage
An in-depth knowledge of discovery toxicology, and experience designing and critically evaluating results of exploratory toxicology studies
Experience of secondary pharmacology assessment would be an advantage
An understanding of in vitro to in vivo translation of potential toxicities and implications for human safety
Broad background in novel methods of identifying potential toxicities and developing risk mitigation plans
Experience with the use of AI tools to predict toxicology endpoints would be an advantage
Highly motivated scientist, who can work independently, with excellent oral/written communication skills
Benefits
Annual bonus
Equity compensation
Comprehensive benefits package
Company
Recursion
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives.
501-1000 employees
H1B Sponsorship
Recursion has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (6)
2024 (6)
2023 (5)
2022 (2)
2021 (1)
Funding
Current Stage
Public CompanyTotal Funding
$865.38MKey Investors
NVIDIAKinnevikLeaps by Bayer
2024-06-26Post Ipo Equity· $200M
2023-07-12Post Ipo Equity· $50M
2022-10-25Post Ipo Equity· $150M
Leadership Team
Chris Gibson
Co-Founder and CEO
Ben Mabey
Chief Technology Officer
Recent News
MenloVentures
2025-12-31
Hartford Business Journal
2025-12-30
felicis.com
2025-12-29
Company data provided by crunchbase